Velarion · Company Intelligence
CompBrief
Fiscal year 2025

Martine Rothblatt — FY2025 total compensation $18,038,972

Martine Rothblatt is Founder, Chairperson, Chief Executive Officer, and Director of UNITED THERAPEUTICS Corp (UTHR). The company reported total compensation of $18,038,972 for fiscal year 2025.

01

Fiscal year 2025 compensation

Salary$1,545,005
Bonus$0
Stock awards$6,067,990
Option awards$6,075,804
Non-equity incentive plan$4,281,875
Pension and non-qualified deferred compensation$55,898
All other compensation$12,400
Total$18,038,972

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.

Cited to the compensation disclosure UNITED THERAPEUTICS Corp filed April 29, 2026, accession 0001082554-26-000009.

03

Peer context

Peer-group chief executive median$15,070,466
Difference from that median$2,968,507
Percentile within the disclosed peer group54th
Peers with a disclosed figure24

Medians and percentiles are computed across the peer group UNITED THERAPEUTICS Corp discloses in its own compensation disclosure.

04

The other named executive officers of UNITED THERAPEUTICS Corp

Named executive officerRoleFY2025 total
Martine Rothblatt this pageFounder, Chairperson, Chief Executive Officer, and Director$18,038,972
Michael BenkowitzPresident and Chief Operating Officer$14,385,655
James EdgemondChief Financial Officer and Treasurer$8,348,367
Paul MahonExecutive Vice President, General Counsel, and Corporate Secretary$5,531,313

The company's named executive officers for fiscal year 2025, and what it reported for each. See the full UNITED THERAPEUTICS Corp compensation brief.

05

The company page

Martine Rothblatt's compensation sits inside UNITED THERAPEUTICS Corp's full executive and board picture — the peer group, pay against peers, incentive design and the board itself.

The UNITED THERAPEUTICS Corp (UTHR) compensation brief